search
Back to results

Adipose-derived MSCs After Enzymatic Digestion vs. Mechanically Fragmented Fat Transfer in Knee Osteoarthritis Treatment

Primary Purpose

Knee Osteoarthritis, Chondropathy

Status
Not yet recruiting
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Autologous adipose derived Mesenchymal Stromal Cells (MSC) injection into the knee joint
Sponsored by
Medical University of Warsaw
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Knee Osteoarthritis focused on measuring MSC, SVF, adipose tissue, knee osteoarthritis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults with symptomatic gonarthrosis diagnosed based on the X-ray, MRI and clinical examination, previously unsuccessfully treated (rehabilitation, NSAIDs, hyaluronic acid, platelet-rich plasma)
  • Primary knee osteoarthritis
  • Willingness and consent to participate in the study
  • Readiness to attend control visits

Exclusion Criteria:

  • Failure to meet the inclusion criteria
  • Active chronic infection
  • Metal implant made of a ferromagnetic material that will exclude the patient from magnetic resonance imaging
  • Use of anticoagulants
  • General and intra-articular use of steroids during the last year
  • Pregnancy, breastfeeding
  • Any autoimmune and rheumatic disease, or conditions that influence the accuracy of test results
  • Taking drugs or cytostatic medications in the last 30 days
  • Mental disorders, alcohol and drug addiction

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Enzymatic digestion group

    Mechanical fragmentation group

    Arm Description

    A group treated with a stromal vascular fraction (SVF) with mesenchymal stromal cells (MSC) injection in the knee joint after an enzymatic digestion of autologous adipose tissue

    A group treated with a mechanically fragmented (using Lipogems device) autologous adipose tissue injection in the knee joint

    Outcomes

    Primary Outcome Measures

    Changes in patients reported outcome measures - Knee Injury and Osteoarthritis Outcome Score (KOOS)
    The KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life.The KOOS's five patient-relevant dimensions are scored separately: Pain (nine items); Symptoms (seven items); ADL Function (17 items); Sport and Recreation Function (five items); Quality of Life (four items). A Likert scale is used and all items have five possible answer options scored from 0 (No problems) to 4 (Extreme problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.
    Changes in flexibility of the knee joint
    Range of motion assessment by goniometer measurements

    Secondary Outcome Measures

    Changes in X-ray imaging of the knee joint in a standing position (AP view)
    Articular cartilage volume evaluation by joint gap measurements
    Changes in MRI with T-2 Mapping of the knee cartilage
    Articular cartilage quality evaluation in T-2 Mapping

    Full Information

    First Posted
    December 14, 2020
    Last Updated
    January 7, 2021
    Sponsor
    Medical University of Warsaw
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04675359
    Brief Title
    Adipose-derived MSCs After Enzymatic Digestion vs. Mechanically Fragmented Fat Transfer in Knee Osteoarthritis Treatment
    Official Title
    Comparison of the Treatment Results of Knee Osteoarthritis Using Adipose Tissue Mesenchymal Stromal Cells Derived Through Enzymatic Digestion and Mechanically Fragmented Adipose Tissue
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2020
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    July 1, 2021 (Anticipated)
    Primary Completion Date
    June 30, 2023 (Anticipated)
    Study Completion Date
    December 1, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Medical University of Warsaw

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The aim of the study is to compare the clinical effects of treatment of knee osteoarthritis using adipose tissue mesenchymal stromal cells obtained by an enzymatic method with the outcomes of the therapy with the mechanically fragmented adipose tissue. Identification and functional analysis of the regenerative capacity of MSCs derived from the adipose tissue depending on three variables (body weight, sex and age) will help to develop a targeted therapy for different groups of patients and will determine the effectiveness of both methods of treatment. An attempt was made to identify the groups of patients with the greatest regeneration potential of the adipose tissue, and thus indicate those with the most probable improvement of the joint condition.
    Detailed Description
    Based on the calculation of the sample size using power analysis of the test, investigators plan to include 100 adults with primary knee osteoarthritis in this study. The patients will undergo lipoaspiration under sterile conditions of the operating theatre, the collected lipoaspirates will be further processed - enzymatically with the use of collagenase or mechanically using the Lipogems system. After collection, lipoaspirates will be immediately transferred to the laboratory of the Department of Regenerative Medicine with a tissue and cells bank in Warsaw, and the preparations will be administered to the patients' knee joints in the operating room under ultrasound control. The Lipogems system is defined as a minimal tissue manipulation system. In contrast, the administration of preparations produced using an enzymatic method requires advanced actions. Lipoaspiration will be performed using blind cannulas and vacuum syringes introduced through the abdominal wall with a three-millimetre incision on the skin after previous injection to the adipose tissue with modified Klein's solution (500 ml of saline solution, 1 ml of adrenaline, 40 ml of 2% lignocaine), which makes the collection easier. 10 ml of the collected adipose tissue will be used to examine the samples after previous gradient drainage from Klein's solution. Immediately after collection, the samples will be sent to the laboratory for analysis (cell count testing, culture, phenotype identification, analysis by flow cytometry). The patients will be monitored in the hospital outpatient clinic for one year after the procedure; the control visits will take place: after 2 and 6 weeks, then after 3 and 6 months and after a year. A physical examination and the assessment using the KOOS questionnaire will be performed. Before the procedure and after one year, an X-ray and MRI with T-2 Mapping will be carried out in order to evaluate the condition of the cartilage.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Knee Osteoarthritis, Chondropathy
    Keywords
    MSC, SVF, adipose tissue, knee osteoarthritis

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    100 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Enzymatic digestion group
    Arm Type
    Active Comparator
    Arm Description
    A group treated with a stromal vascular fraction (SVF) with mesenchymal stromal cells (MSC) injection in the knee joint after an enzymatic digestion of autologous adipose tissue
    Arm Title
    Mechanical fragmentation group
    Arm Type
    Active Comparator
    Arm Description
    A group treated with a mechanically fragmented (using Lipogems device) autologous adipose tissue injection in the knee joint
    Intervention Type
    Procedure
    Intervention Name(s)
    Autologous adipose derived Mesenchymal Stromal Cells (MSC) injection into the knee joint
    Other Intervention Name(s)
    Autologous mechanically fragmented adipose tissue injection into the knee joint using Lipogems device
    Intervention Description
    Injections of the two adipose tissue derived products containing MSCs into the knee joints with osteoarthritis
    Primary Outcome Measure Information:
    Title
    Changes in patients reported outcome measures - Knee Injury and Osteoarthritis Outcome Score (KOOS)
    Description
    The KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life.The KOOS's five patient-relevant dimensions are scored separately: Pain (nine items); Symptoms (seven items); ADL Function (17 items); Sport and Recreation Function (five items); Quality of Life (four items). A Likert scale is used and all items have five possible answer options scored from 0 (No problems) to 4 (Extreme problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.
    Time Frame
    1,3,6 and 12 months after procedure
    Title
    Changes in flexibility of the knee joint
    Description
    Range of motion assessment by goniometer measurements
    Time Frame
    1,3,6, and 12 months after procedure
    Secondary Outcome Measure Information:
    Title
    Changes in X-ray imaging of the knee joint in a standing position (AP view)
    Description
    Articular cartilage volume evaluation by joint gap measurements
    Time Frame
    6 months and 1 year after procedure
    Title
    Changes in MRI with T-2 Mapping of the knee cartilage
    Description
    Articular cartilage quality evaluation in T-2 Mapping
    Time Frame
    6 months and 1 year after procedure

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Adults with symptomatic gonarthrosis diagnosed based on the X-ray, MRI and clinical examination, previously unsuccessfully treated (rehabilitation, NSAIDs, hyaluronic acid, platelet-rich plasma) Primary knee osteoarthritis Willingness and consent to participate in the study Readiness to attend control visits Exclusion Criteria: Failure to meet the inclusion criteria Active chronic infection Metal implant made of a ferromagnetic material that will exclude the patient from magnetic resonance imaging Use of anticoagulants General and intra-articular use of steroids during the last year Pregnancy, breastfeeding Any autoimmune and rheumatic disease, or conditions that influence the accuracy of test results Taking drugs or cytostatic medications in the last 30 days Mental disorders, alcohol and drug addiction
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Anna Krześniak, MD
    Phone
    +48600104793
    Email
    anna.krzesniak@gmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Artur Stolarczyk, MD, PhD
    Email
    drstolarczyk@gmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Artur Stolarczyk, MD, PhD
    Organizational Affiliation
    Medical University of Warsaw
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    33655941
    Citation
    Krzesniak AM, Radzimowski K, Stolarczyk A. Comparison of the treatment results of knee osteoarthritis using adipose tissue mesenchymal stromal cells derived through enzymatic digestion and mechanically fragmented adipose tissue. Medicine (Baltimore). 2021 Mar 5;100(9):e24777. doi: 10.1097/MD.0000000000024777.
    Results Reference
    derived

    Learn more about this trial

    Adipose-derived MSCs After Enzymatic Digestion vs. Mechanically Fragmented Fat Transfer in Knee Osteoarthritis Treatment

    We'll reach out to this number within 24 hrs